Ian Poulton

15.3k total citations
32 papers, 1.3k citations indexed

About

Ian Poulton is a scholar working on Infectious Diseases, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ian Poulton has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 12 papers in Immunology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ian Poulton's work include Tuberculosis Research and Epidemiology (9 papers), Immunodeficiency and Autoimmune Disorders (8 papers) and Mosquito-borne diseases and control (8 papers). Ian Poulton is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Immunodeficiency and Autoimmune Disorders (8 papers) and Mosquito-borne diseases and control (8 papers). Ian Poulton collaborates with scholars based in United Kingdom, United States and Gambia. Ian Poulton's co-authors include Adrian V. S. Hill, Helen McShane, Angela M. Minassian, Sarah C. Gilbert, Susanna Dunachie, Laura Andrews, Tamara Berthoud, Iman Satti, Helen A. Fletcher and Robert E. Sinden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ian Poulton

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian Poulton United Kingdom	20	569	552	447	356	329	32	1.3k
Jenni M. Vuola Finland	15	424 0.7×	440 0.8×	269 0.6×	457 1.3×	248 0.8×	25	1.1k
Sarah Sebastian United Kingdom	20	484 0.9×	527 1.0×	317 0.7×	532 1.5×	462 1.4×	35	1.5k
Dylan Davey United States	5	438 0.8×	998 1.8×	321 0.7×	532 1.5×	226 0.7×	6	1.6k
Matthew D. J. Dicks United Kingdom	17	479 0.8×	377 0.7×	214 0.5×	259 0.7×	309 0.9×	21	1.1k
Dominick J. Laddy United States	20	613 1.1×	675 1.2×	158 0.4×	513 1.4×	235 0.7×	25	1.3k
Tom Blanchard United Kingdom	17	415 0.7×	771 1.4×	261 0.6×	474 1.3×	480 1.5×	28	1.5k
Ulrike Wille-Reece United States	14	211 0.4×	1.1k 2.0×	250 0.6×	376 1.1×	401 1.2×	18	1.6k
V. Ann Stewart United States	20	239 0.4×	639 1.2×	1.0k 2.3×	223 0.6×	461 1.4×	42	1.6k
Thong P. Le United States	8	220 0.4×	658 1.2×	745 1.7×	229 0.6×	636 1.9×	10	1.5k
Martine Delchambre United Kingdom	11	201 0.4×	409 0.7×	710 1.6×	285 0.8×	481 1.5×	13	1.3k

Countries citing papers authored by Ian Poulton

Since Specialization

Citations

This map shows the geographic impact of Ian Poulton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Poulton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Poulton more than expected).

Fields of papers citing papers by Ian Poulton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Poulton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Poulton. The network helps show where Ian Poulton may publish in the future.

Co-authorship network of co-authors of Ian Poulton

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Poulton. A scholar is included among the top collaborators of Ian Poulton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Poulton. Ian Poulton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jenkin, Daniel, Rebecca Makinson, Helen Sanders, et al.. (2025). Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial. The Lancet Microbe. 6(5). 101022–101022. 1 indexed citations

Jenkin, Daniel, Adam Ritchie, Jeremy Aboagye, et al.. (2022). Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial. The Lancet Microbe. 3(9). e663–e671. 15 indexed citations

Folegatti, Pedro M., Amy Flaxman, Daniel Jenkin, et al.. (2021). Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies. Vaccines. 9(3). 262–262. 4 indexed citations

Tuthill, Mark, Federica Cappuccini, Emily Pollock, et al.. (2020). 682P Results from ADVANCE: A phase I/II open-label non-randomised safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 (VTP-800) vaccine in combination with PD-1 checkpoint blockade in metastatic prostate cancer. Annals of Oncology. 31. S543–S543. 4 indexed citations

Bliss, Carly M., Georgina Bowyer, Nicholas Anagnostou, et al.. (2018). Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP. Scientific Reports. 8(1). 3390–3390. 29 indexed citations

Churcher, Thomas S., Nick J. Edwards, Ian Poulton, et al.. (2017). PROBABILITY OF TRANSMISSION OF MALARIA FROM MOSQUITO TO HUMAN IS REGULATED BY PARASITE DENSITY IN NAIVE AND VACCINATED HOSTS. American Journal of Tropical Medicine and Hygiene. 97. 230–230. 1 indexed citations

Churcher, Thomas S., Robert E. Sinden, Nick J. Edwards, et al.. (2017). Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts. PLoS Pathogens. 13(1). e1006108–e1006108. 79 indexed citations

Venkatraman, Navin, Nicholas Anagnostou, Carly M. Bliss, et al.. (2017). Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™. Vaccine. 35(45). 6208–6217. 29 indexed citations

Sheehy, Susanne H., Alexandra J. Spencer, Alexander D. Douglas, et al.. (2013). Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe. PLoS ONE. 8(6). e65960–e65960. 54 indexed citations

10.

Meyer, Joel N., Iman Satti, Leanne Marsay, et al.. (2013). Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination. The Journal of Infectious Diseases. 209(8). 1259–1268. 59 indexed citations

11.

Meyer, Joel N., Stephanie A. Harris, Iman Satti, et al.. (2012). Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery. Vaccine. 31(7). 1026–1033. 51 indexed citations

12.

Rowland, Rosalind, Ansar A. Pathan, Iman Satti, et al.. (2012). Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults. Human Vaccines & Immunotherapeutics. 9(1). 50–62. 21 indexed citations

13.

Thompson, Fiona M., David W. Porter, Shinji L. Okitsu, et al.. (2011). Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial. PLoS ONE. 6(2). 3 indexed citations

14.

Porter, David W., Fiona M. Thompson, Tamara Berthoud, et al.. (2011). A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine. Vaccine. 29(43). 7514–7522. 39 indexed citations

15.

Sander, Clare R., Ansar A. Pathan, Natalie E. R. Beveridge, et al.. (2009). Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis –infected Individuals. American Journal of Respiratory and Critical Care Medicine. 179(8). 724–733. 94 indexed citations

16.

Pathan, Ansar A., Clare R. Sander, Helen A. Fletcher, et al.. (2009). Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A. PLoS ONE. 4(6). e5934–e5934. 52 indexed citations

17.

Thompson, Fiona M., David W. Porter, Shinji L. Okitsu, et al.. (2008). Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial. PLoS ONE. 3(1). e1493–e1493. 83 indexed citations

18.

Dunachie, Susanna, Samuel McConkey, Ian Poulton, et al.. (2006). Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers. Vaccine. 24(15). 3026–3034. 54 indexed citations

19.

Dunachie, Susanna, Michael Walther, Jenni M. Vuola, et al.. (2006). A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS. Vaccine. 24(15). 2850–2859. 77 indexed citations

20.

Webster, Daniel P., Susanna Dunachie, Jenni M. Vuola, et al.. (2005). Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proceedings of the National Academy of Sciences. 102(13). 4836–4841. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact